Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 13 of 13 for “"Gardasil"”.
-
Because We Have the Power to Choose: A Critical Analysis of the Rhetorical Strategies Used in Merck's Gardasil Campaign
In June of 2006, Merck gained FDA approval for Gardasil, a human papillomavirus vaccine. Shortly before, Merck also launched a large campaign to advertise the vaccine, which has continued through today. Because of the vast number of women the vaccine has the potential to affect, the product has …
-
Because We Have the Power to Choose: A Critical Analysis of the Rhetorical Strategies Used in Merck's Gardasil Campaign
In June of 2006, Merck gained FDA approval for Gardasil, a human papillomavirus vaccine. Shortly before, Merck also launched a large campaign to advertise the vaccine, which has continued through today. Because of the vast number of women the vaccine has the potential to affect, the product has …
-
The vaccine and the virus: An autoethnographic account of HPV, sex education, and the psychosocial effects of STI's
… Food and Drug Administration (FDA) approved the Gardasil vaccine to assist in the protection from the Human Papillomavirus (HPV): The leading contributor to cervical cancer. After stressing the importance of the vaccine, but disregarding its inadequacies, young women were subjected to invasive …
-
Vaccination Nation: A Bioethical Feminist Inquiry into the Political, Social and Ethical Controversy Surrounding the Human Papillomavirus Vaccine
… in this country whether this new HPV vaccine, Gardasil®, should be added to the list of school-mandated vaccines. Karen Houppert (2007) has stated that this particular "vaccine protects girls and women from cervical cancer and genital warts caused by the human papillomavirus (HPV)" (p. 17). So, …
-
Juvenile onset Recurrent Respiratory Papillomatosis (JoRRP) at Red Cross War Memorial Children’s Hospital, Cape Town: A 2-year review
… 1 to 164 weeks (median 9 weeks). Four received Gardasil vaccination as adjuvant therapy, 3 of who showed a reduction in disease severity. Conclusion: JoRRP commonly presents around the first 3 years of life. Severe cases can be life-threatening, often with multiple hospital admissions for …
-
Production and immunogenicity of chimaeric human papillomavirus-like particle vaccines
… Two vaccines are available on the market: Gardasil(R), targeted against HPV -16, -18; -6 and -11, and Cervarix(TM), against -16 and -18. Both vaccines are based on the L1 capsid proteins of the types they are targeted to and are efficient, pro- phylactic, typespecific vaccines. However, two …
-
Novel intranasal GNRs-DNA vaccines against human papillomavirus infection
Currently licensed HPV vaccines, Cervarix and Gardasil, have been successfulin preventing HPV infection and high-graded cervical intraepithelial neoplasia (CIN2,3) in school girls in the UK and other developed countries. However, their high costshave hindered their wider use in preventing HPV …
-
HPV pseudovirion production in plants
… available vaccines, namely Cervarix™ and Gardasil®. Cervarix offers protection against high-risk HPV types 16 and 18, while Gardasil offers further protection against types 6 and 11. Both of these vaccines are based on major capsid protein L1 Virus-like particles (VLPs). While these …
-
Making evidence, making legitimacy : the introduction of HPV (Human Papillomavirus) vaccines in Colombia
… In 2013 the Colombian government introduced Gardasil® (Merck’s HPV vaccine) into the Colombian Expanded Programme of Immunisation. Since that year, three million girls have received the vaccine in Colombia. This thesis offers an empirical analysis of the configurations of evidence, efficiency …
-
What college women know, think, and do about Human Papillomavirus (HPV) and HPV vaccine
… to 24 year old age group. In 2006, HPV vaccine (Gardasil®) was approved for girls and women aged 9 to 26. However, the national vaccine uptake rate among young women has been low. HPV vaccine mandatory proposals have also been met with controversy. Some advocacy groups have voiced concerns about …
-
The Immunogenicity of Plant-produced Human Papillomavirus (HPV) Virus-like particles (VLPs) in Mice
… immunization in mice. The commercially available Gardasil® HPV VLP vaccine was used as a positive control. The immunogenicity of the vaccines was evaluated by testing for the presence of anti-L1 antibodies in sera from immunized mice using enzyme-linked immunosorbent assays (ELISAs) and western …
-
Chlamydia trachomatis diversity and pathogenesis in young South African women, related to HPV prevalence and risk
… the need for a broader vaccination strategy (eg. Gardasil®9). Public health initiatives are needed to be implemented to reduce the burden of clinically asymptomatic but inflammation causing infections with CT among young women by wider roll-out of near pointof-care (POC) or true POC STI screening …